Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

Biden hopes abortion will keep him in the White House. But has he done enough to protect rights?

The president has made big promises and held the line against legal challenges, but activists say he could be doing more

The Guardian - US

Robitussin Cough Syrups Recalled Due To Microbial Contamination

The distributors have been notified and provided with instructions for the return of all recalled products.

Medical Daily

Here's how the Pixel 8 Pro's FDA-cleared body temperature sensor works

Google recently added support for taking your body's temperature with the Pixel 8 Pro, and this is how the feature works.

Android Central

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Lucrative Biotech Stock Buys for Success

The development of orphan medications, innovative biotech equipment, personalized medicine, and strong government support are all contributing to the biotech industry's upward trajectory. Thus, lucrative biotech stocks Vertex Pharmaceuticals (VRTX), Innoviva (INVA), and Organogenesis Holdings (ORGO) could be ideal additions to your portfolio right now. Read more….

StockNews.com

Senator Chuck Schumer calls for federal shutdown on Zen nicotine pouches

This news report highlights Senator Chuck Schumer's call for a federal shutdown on Zen nicotine pouches due to concerns over its impact on young people.

Top News

Will These 3 Biotech Stocks Make Gains in 2024?

In the swiftly progressing arena of biotechnology, technological advancements, increasing merger and acquisition maneuvers, and developing product pipelines are driving significant expansion in this sector. The sector's strong potential is further reinforced by a steady demand, ensuring its sustenance. Given this backdrop, let’s analyze whether or not biotech stocks Illumina…

StockNews.com

The January 2024 Pixel feature drop unlocks the full potential of your temperature sensor

A slew of features will be rolling out this morning for Pixel users as part of the January 2024 feature drop. This includes a fully realized temperature sensor, Magic Compose, and more.

Android Central

Read news from The Economist, FT, and more,
with one subscription

3 Biotech Stock Gems Bursting With Buy Opportunities

The biotech industry is well poised to flourish, buoyed by its commitment to innovation and potential for groundbreaking discoveries. Thus, investing in the shares of three fundamentally solid biotech companies, Foghorn Therapeutics (FHTX), Jazz Pharmaceuticals (JAZZ), and Gilead Sciences (GILD), might be prudent. Continue reading….

StockNews.com

Promising Blood Test Shows Early Alzheimer's Detection Potential

A new study suggests a promising blood test that could diagnose Alzheimer's disease accurately and early, potentially revolutionizing dementia care.

Top News

Top-Notch Pharvaris Eyes Profit-Taking Zone On A Key FDA Decision

Top-notch biotech stock Pharvaris surged Monday after the FDA said it could begin testing a treatment for a swelling disorder in people.

Investors Business Daily

In Washington state, pharmacists are poised to start prescribing abortion drugs

They're pioneering a new model of care that will allow for one-stop, same-day access to mifepristone — no appointment necessary.

WEKU

Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks

ARK Innovation, the flagship Cathie Wood ETF, is skidding in 2024 as the S&P 500 hits a record high. Blame Coinbase, Tesla and other big ARKK ETF holdings.

Investors Business Daily

Menthol cigarette ban decision delayed again, sparking public pressure

This informative article discusses the push to ban menthol cigarettes and its potential impact on public health, particularly in black communities.

Top News

SCOTUS hears oral argument in challenge to Chevron deference

The Checks and Balances Letter delivers news and information from Ballotpedia’s Administrative State Project, including pivotal actions at the federal and state levels related to the separation of powers, due process, and the rule of law.

Ballotpedia

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Biden Administration Policy Jeopardizes The System That Gave Us Gene Editing

The White House just released a proposal that would allow federal agencies to rip up patent licensing agreements between universities -- which may receive federal research funds -- and private companies, including biotech firms.

Salon

Why people are taking bovine colostrum

Bovine colostrum supplements are taking over, but the evidence for some claims is lacking

DermaSensor announces AI skincare device that detects three common skin cancers

It's been FDA approved as of yesterday

Top News

Governor supports potential reclassification of marijuana as per FDA recommendation

In this informative response, Governor Haley discusses the potential reclassification of marijuana as well as the importance of allowing states to decide i...

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - US

Generic drugs in the US are too cheap to be sustainable, experts say

Non-brand-name drugs are one inexpensive part of the healthcare system but they’re driving some manufacturers out of business

Salon

"Faux-zempic" driving hospitalizations

Experts warn against the risks of illegitimately obtained Ozempic and Wegovy

Salon

FDA failing children with rare disease

The FDA is holding potential Sanfilippo syndrome therapies to an impossible and inhumane standard

Tom’s Guide

Should you take melatonin gummies to fall asleep fast? Here's what a doctor thinks

Two sleep doctors answer everything you need to know about melatonin gummies, including the side effects, how long they last and how many you should take.

Investors Business Daily

Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock

Crispr won its second gene-editing approval on Tuesday — two months ahead of time. But CRSP stock slipped, and VRTX stock rose minimally.

WEKU

What would a second Trump presidency look like for health care?

The former president is reviving campaign promises to undo Obamacare, an idea that fizzled during his first time in office. Based on his record, here's what else he might do in health policy.

Reason

The Newly Unveiled HHS Rationale for Rescheduling Marijuana Underlines Drug Warriors' Dishonesty

The points about marijuana's risks and benefits that the department now concedes were clear long before last August.

1 … 34 35 36 37

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.